 | | PRD_000768 | | Name: | CYCLOSPORIN A, 8 mutation | | Formula: | C62 H111 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A MOLECULE WAS MODIFIED AT
POSITION 8 TO BE N-METHYL-ISOLEUCINE | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000769 | | Name: | 2-{(3S)-3-[(benzylsulfonyl)amino]-2-oxopiperidin-1-yl}-N-{(2S)-1-[(3S)-1-carbamimidoylpiperidin-3-yl]-3-oxopropan-2-yl}acetamide | | Formula: | C23 H34 N6 O5 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000770 | | Name: | (5S, 8R, 11S)-14-[4-(BENZYLOXY)-4-OXOBUTANOYL]-8-(2-CARBOXYETHYL)-5-(CARBOXYMETHYL)-11-
(1-METHYLETHYL)-3,6,9,12-TETRAOXO-1-PHENYL-2-OXA-4,7,10,13,14-PENTAAZAHEXADECAN-16-OIC ACID | | Formula: | C35 H43 N5 O14 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000771 | | Name: | Peptide aldehyde inhibitor Ac-NSTSQ-H | | Formula: | C21 H37 N7 O11 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000772 | | Name: | Peptide aldehyde inhibitor Ac-ESTLQ-H | | Formula: | C25 H44 N6 O11 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000779 | | Name: | D-PEPTIDE INHIBITOR PIE71 | | Formula: | C89 H127 N22 O20 S2 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000781 | | Name: | Thr-Asp-F-amidine | | Formula: | C17 H29 F N6 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000782 | | Name: | Nalpha-[(benzyloxy)carbonyl]-N-[(2S)-1-(4-tert-butoxyphenyl)-4-hydroxy-3-oxobutan-2-yl]-L-phenylalaninamide | | Formula: | C31 H36 N2 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000784 | | Name: | Nalpha-[(benzyloxy)carbonyl]-N-[(1S)-1-(4-tert-butoxybenzyl)-3-diazo-2-oxopropyl]-L-phenylalaninamide | | Formula: | C31 H34 N4 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000785 | | Name: | Largazole | | Formula: | C21 H29 N4 O4 S3 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000786 | | Name: | Peptide inhibitor (ACE)VDV(3PX)D-CHO | | Formula: | C28 H47 N5 O11 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000787 | | Name: | D-phenylalanyl-N-[(4-chloropyridin-3-yl)methyl]-L-prolinamide | | Formula: | C20 H23 Cl N4 O2 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000788 | | Name: | D-phenylalanyl-N-[(4-chloropyridin-2-yl)methyl]-L-prolinamide | | Formula: | C20 H23 Cl N4 O2 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000790 | | Name: | D-phenylalanyl-N-(pyridin-2-ylmethyl)-L-prolinamide | | Formula: | C20 H24 N4 O2 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000793 | | Name: | ACE-AEIK-CHO ALDEHYDE peptide inhibitor | | Formula: | C22 H41 N5 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000794 | | Name: | C6H5(CH2)8-derivatized peptide inhibitor | | Formula: | C40 H63 N8 O11 P | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000795 | | Name: | D-phenylalanyl-N-(pyridin-4-ylmethyl)-L-prolinamide | | Formula: | C20 H24 N4 O2 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000796 | | Name: | methyl N-[(2S)-1-[[(2S,3S,5S)-5-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-3-oxidanyl-6-phenyl-1-(4-pyridin-3-ylphenyl)hexan-2-yl]amino]-3,3-dimethyl-1-oxidanylidene-butan-2-yl]carbamate | | Formula: | C39 H53 N5 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000797 | | Name: | (2S)-2-[(N-acetyl-L-alpha-aspartyl)amino]nonanoic acid | | Formula: | C15 H26 N2 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000798 | | Name: | (3R,3aR,5R,6aR)-3-hydroxyhexahydro-2H-cyclopenta[b]furan-5-yl [(2S,3R)-3-hydroxy-4-{[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino}-1-phenylbutan-2-yl]carbamate | | Formula: | C29 H40 N2 O8 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000799 | | Name: | N-acetyl-L-alpha-aspartyl-L-methionine | | Formula: | C11 H18 N2 O6 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000800 | | Name: | N-[3-(3-phenylisoxazol-5-yl)propanoyl]-L-alpha-glutamyl-L-alpha-glutamyl-amide | | Formula: | C22 H26 N4 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000801 | | Name: | N-(benzylsulfonyl)-D-leucyl-N-[2-(aminomethyl)-5-chlorobenzyl]-L-prolinamide | | Formula: | C26 H35 Cl N4 O4 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000802 | | Name: | D-phenylalanyl-N-[(1-methylpyridinium-2-yl)methyl]-L-prolinamide | | Formula: | C21 H27 N4 O2 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000803 | | Name: | N-{3-[3-(3'-chlorobiphenyl-4-yl)isoxazol-5-yl]propanoyl}-L-alpha-glutamyl-L-alpha-glutamyl-amide | | Formula: | C28 H29 Cl N4 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
